Skip to main content
. 2006 Oct 18;2006(4):CD004510. doi: 10.1002/14651858.CD004510.pub3

Al‐Asseri 2001.

Methods DETAILS OF STUDY
AIM OF INTERVENTION: whether post‐discharge care counseling was a factor in improving patients' overall compliance with treatment in a hospital setting.
AIM OF STUDY: To test whether counseling of surgical and cardiac patients by a pharmacist would improve patients' drug compliance.
STUDY DESIGN: CCT.
METHODS OF RECRUITMENT OF PARTICIPANTS: unclear.
INCLUSION CRITERIA FOR PARTICIPATION IN STUDY: at least 3 medications and having a scheduled appointment at 8 weeks in hospital.
EXCLUSION CRITERIA FOR PARTICIPATION IN STUDY: mental illness.
INFORMED CONSENT OBTAINED? yes.
ETHICAL APPROVAL? unclear.
FUNDING: unclear.
ASSESSMENT OF STUDY QUALITY
ALLOCATION CONCEALMENT: unclear.
EPOC‐ QUALITY CRITERIA 2002: C.high risk of bias.
METHOD OF GENERATING RANDOMISATION SCHEDULE: number assigned: odd number in control, even numbers in intervention.
METHOD OF CONCEALMENT OF ALLOCATION: as above, no further information given.
BLINDING: 
 ·PARTICIPANTS: no. 
 ·PROVIDER/S: no. 
 ·OUTCOME ASSESSOR/S: no.
INTENTION TO TREAT ANALYSIS: not stated.
BASELINE COMPARABILITY OF INTERVENTION AND CONTROL GROUPS: not stated.
STATISTICAL METHODS AND THEIR APPROPRIATENESS: chi‐square.
CONSUMER INVOLVEMENT: not stated.
Participants DESCRIPTION : cardiac patients / surgery patients.
GEOGRAPHIC LOCATION: Saudi Arabia.
SETTING: discharged home from an acute care setting.
NUMBER OF PARTICIPANTS: 
 ELIGIBLE: unclear. 
 RANDOMISED TO INTERVENTION: 36. 
 RANDOMISED TO CONTROL: 36. 
 INCLUDED IN ANALYSIS INTERVENTION GROUP: 36. 
 INCLUDED IN ANALYSIS CONTROL GROUP: 36.
AGE: RANGE OR MEAN (SD): 18‐70.
GENDER (% MALE): 50.
ETHNICITY: unclear.
PRINCIPAL HEALTH PROBLEM OR DIAGNOSIS: unclear.
OTHER HEALTH PROBLEM/S: unclear.
TREATMENT RECEIVED/RECEIVING: unclear.
OTHER SOCIAL/DEMOGRAPHIC DETAILS: not given.
Interventions DETAILS OF INTERVENTION: A pharmacist counseled patients on day of discharge about indication of drug use, expected therapeutic outcome, dosage and method of administration, storage conditions, duration of therapy and what to do when a dose is missed. The pharmacist gave TFU every 3 days for up to eight weeks; also patients could call pharmacist when they needed further counseling.
DETAILS OF CONTROL: usual care.
CO‐INTERVENTION? yes.
DETAILS OF CO‐INTERVENTIONS: access to the pharmacist by phone (in intervention group only) and counseling by pharmacist on discharge day (both groups).
DELIVERY OF INTERVENTION: 
 Frequency: 18. First time at day 3 after discharge. Period: 8 weeks (range 2 to 8)
PROVIDERS: pharmacist.
INTERVENTION QUALITY: unclear how much intervention was given in each patient.
FIDELITY/INTEGRITY: unclear.
Outcomes NUMBER OF OUTCOMES: 3.
OUTCOME / TOOL / TOOL VALIDATED / METHOD OF ASSESSMENT / TIME OF ASSESSMENT: 
 A.Psycho‐social health of patients (uncertainty, anxiety, informational needs, mood, coping, quality of life, social activity, ..): satisfaction / self‐developed / no / interview / 8 weeks after discharge. 
 B.Physical health of patients (e.g. functional status, self‐care, self‐efficacy, independence, ..): 
 C.Other consumer oriented outcomes (e.g. treatment adherence, knowledge, adverse events, ..): compliance / self‐developed / no / interview / 8 weeks after discharge. Drugs‐related side‐effects / self‐developed / no / interview / 8 weeks after discharge. 
 D. Health service delivery oriented outcomes (eg. hospital readmission, health services utilization, ..):
Notes ·CHANGES IN TRIAL PROTOCOL
·CONTACT WITH AUTHOR
·POWER CALCULATION?
·RECORD IF THE STUDY WAS TRANSLATED FROM A LANGUAGE OTHER THAN ENGLISH.
·RECORD IF THE STUDY WAS A DUPLICATE PUBLICATION.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear